24 Nov 2015
'Academic Drug Discovery III' took place at SCI in London on Tuesday 24 November 2015.
This event showcased a range of drug discovery programmes and provided illustrations of how different types of collaborations have led, and are leading to, successful drug candidates. Representatives from key groups in academia and those involved in transferring this technology to the pharmaceutical industry were in attendance.
Available conference papers
- TTO's - a challenging business to build - Kristin Sandereid, Inven2, Norway
- Drug discovery and academia - can I be bothered? - Andy Merritt, Medical Research Council Technology, UK
- The discovery of therapeutics for neglected diseases and the translation of novel biology through small molecule drug discovery - Paul Wyatt, University of Dundee, UK
- Chemists in academia and industry, working together to discover new drug targets for common and rare diseases (cancer, inflammatory and neuro-psychiatric) - Chas Bountra, SGC Oxford, UK